Welcome to our dedicated page for HIPOW SEC filings (Ticker: HIPOW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hippo Holdings Inc. filings document corporate governance, proxy voting, and material-event disclosures for the issuer associated with the HIPOW securities. The record includes definitive proxy statements for annual meeting matters and Form 8-K reporting on board composition, director appointments, committee assignments, and related governance disclosures.
The filings also identify the company's registered common stock, listed on the New York Stock Exchange under HIPO, and provide formal disclosure around governance structure, stockholder meeting procedures, and changes reported under Exchange Act requirements.
Hippo Holdings Inc. received a notice that an individual security holder plans to sell 5,000 shares of its common stock under Rule 144. The shares were originally acquired as 5,000 restricted stock units from Hippo Holdings Inc. on 12/24/2020. The planned sale is to be executed through Merrill Lynch on the NYSE around 01/09/2026, with an indicated aggregate market value of $157,600 and with 25,335,179 common shares outstanding. The form also reports that the same seller disposed of 5,000 common shares on 12/09/2025 for gross proceeds of $149,100 during the prior three months.
Hippo Holdings Inc. received a notice that an individual security holder plans to sell 5,000 shares of its common stock under Rule 144. The shares were originally acquired as 5,000 restricted stock units from Hippo Holdings Inc. on 12/24/2020. The planned sale is to be executed through Merrill Lynch on the NYSE around 01/09/2026, with an indicated aggregate market value of $157,600 and with 25,335,179 common shares outstanding. The form also reports that the same seller disposed of 5,000 common shares on 12/09/2025 for gross proceeds of $149,100 during the prior three months.
An insider of the company with ticker HIPO has filed a notice to sell 3,900 shares of its common stock through broker Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an aggregate market value of $120,471.00, compared with 25,335,179 shares outstanding of the same class. The securities to be sold were acquired from the issuer as restricted stock units and performance stock units on 08/15/2025 and 09/10/2025, in amounts of 2,627 and 1,273 shares respectively, with payment noted as non-cash. The filer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
An insider of the company with ticker HIPO has filed a notice to sell 3,900 shares of its common stock through broker Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an aggregate market value of $120,471.00, compared with 25,335,179 shares outstanding of the same class. The securities to be sold were acquired from the issuer as restricted stock units and performance stock units on 08/15/2025 and 09/10/2025, in amounts of 2,627 and 1,273 shares respectively, with payment noted as non-cash. The filer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Hippo Holdings Inc. director reports charitable stock gift
A director of Hippo Holdings Inc. reported donating 4,935 shares of common stock on 12/18/2025 in a transaction coded as a gift at a price of $0.00 per share. After this donation, the director beneficially owns 16,563 shares of common stock directly, including 4,738 restricted stock units, and 50,000 shares indirectly through Janajasa Associates L.P. The filing reflects a personal charitable transfer rather than an open-market sale.
Hippo Holdings Inc. director reports charitable stock gift
A director of Hippo Holdings Inc. reported donating 4,935 shares of common stock on 12/18/2025 in a transaction coded as a gift at a price of $0.00 per share. After this donation, the director beneficially owns 16,563 shares of common stock directly, including 4,738 restricted stock units, and 50,000 shares indirectly through Janajasa Associates L.P. The filing reflects a personal charitable transfer rather than an open-market sale.
Hippo Holdings Inc. insider activity: Chief Executive Officer and director Richard McCathron reported selling 5,000 shares of Hippo common stock on 12/09/2025 at a price of $29.82 per share. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan dated August 29, 2025, which is designed to allow insiders to sell shares according to a preset schedule. Following this transaction, McCathron beneficially owns 452,704 shares of Hippo common stock, which includes 181,675 restricted stock units (RSUs).
Hippo Holdings Inc. insider activity: Chief Executive Officer and director Richard McCathron reported selling 5,000 shares of Hippo common stock on 12/09/2025 at a price of $29.82 per share. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan dated August 29, 2025, which is designed to allow insiders to sell shares according to a preset schedule. Following this transaction, McCathron beneficially owns 452,704 shares of Hippo common stock, which includes 181,675 restricted stock units (RSUs).
Hippo Holdings Inc. has a planned sale of restricted stock reported under Rule 144. The notice covers up to 5,000 shares of common stock to be sold through Merrill Lynch on the NYSE, with an aggregate market value of $149,100. These shares were acquired as restricted stock units from Hippo Holdings Inc. on 05/15/2023, in the same amount of 5,000 shares.
The filing states that 25,335,179 shares of the issuer’s common stock were outstanding, providing context on the size of the planned sale relative to the overall share base. The approximate sale date listed is 12/09/2025.
Hippo Holdings Inc. has a planned sale of restricted stock reported under Rule 144. The notice covers up to 5,000 shares of common stock to be sold through Merrill Lynch on the NYSE, with an aggregate market value of $149,100. These shares were acquired as restricted stock units from Hippo Holdings Inc. on 05/15/2023, in the same amount of 5,000 shares.
The filing states that 25,335,179 shares of the issuer’s common stock were outstanding, providing context on the size of the planned sale relative to the overall share base. The approximate sale date listed is 12/09/2025.
Hippo Holdings (HIPO) has a Form 144 notice covering a planned sale of 3,645 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an aggregate market value of 115,109.10 and are part of a larger base of 25,335,000 shares outstanding. The proposed sale date is 11/21/2025. The seller acquired 1,553 shares via restricted stock units on 05/15/2025 and 2,092 shares via performance stock units on 09/09/2025, both from the issuer. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about Hippo’s current or prospective operations.
Hippo Holdings (HIPO) has a Form 144 notice covering a planned sale of 3,645 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an aggregate market value of 115,109.10 and are part of a larger base of 25,335,000 shares outstanding. The proposed sale date is 11/21/2025. The seller acquired 1,553 shares via restricted stock units on 05/15/2025 and 2,092 shares via performance stock units on 09/09/2025, both from the issuer. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about Hippo’s current or prospective operations.
Hippo Holdings Inc. (HIPO) reported an insider equity transaction by its GM & Chief Insurance, HHIP, Michael Stienstra. On 11/15/2025, a disposition coded "F" of 2,463 shares of common stock at $31.1137 per share was reported. After this transaction, Stienstra beneficially owned 75,181 shares, which includes 37,874 restricted stock units (RSUs). The filing reflects routine reporting of changes in an executive’s equity holdings.
Hippo Holdings Inc. (HIPO) reported an insider equity transaction by its GM & Chief Insurance, HHIP, Michael Stienstra. On 11/15/2025, a disposition coded "F" of 2,463 shares of common stock at $31.1137 per share was reported. After this transaction, Stienstra beneficially owned 75,181 shares, which includes 37,874 restricted stock units (RSUs). The filing reflects routine reporting of changes in an executive’s equity holdings.
Hippo Holdings Inc. (HIPO) reported an insider transaction by an officer identified as CEO Spinnaker. On 11/15/2025, the reporting person disposed of 2,123 shares of common stock in a transaction marked with code F at a price of $31.1137 per share. After this transaction, the reporting person beneficially owned 58,852 shares of Hippo common stock.
The reported holdings include 47,549 restricted stock units (RSUs), indicating that a significant portion of the position is in the form of equity awards that typically settle into shares over time.
Hippo Holdings Inc. (HIPO) reported an insider transaction by an officer identified as CEO Spinnaker. On 11/15/2025, the reporting person disposed of 2,123 shares of common stock in a transaction marked with code F at a price of $31.1137 per share. After this transaction, the reporting person beneficially owned 58,852 shares of Hippo common stock.
The reported holdings include 47,549 restricted stock units (RSUs), indicating that a significant portion of the position is in the form of equity awards that typically settle into shares over time.
Hippo Holdings Inc. (HIPO) reported that Chief Executive Officer and director Richard McCathron disposed of 11,326 shares of common stock on 11/15/2025 at a price of $31.1137 per share. After this transaction, he beneficially owns 457,704 shares of Hippo common stock, which the disclosure states includes 181,675 restricted stock units (RSUs). The filing is made on Form 4 as a single-reporting-person filing for McCathron in his roles as both director and officer.
Hippo Holdings Inc. (HIPO) reported that Chief Executive Officer and director Richard McCathron disposed of 11,326 shares of common stock on 11/15/2025 at a price of $31.1137 per share. After this transaction, he beneficially owns 457,704 shares of Hippo common stock, which the disclosure states includes 181,675 restricted stock units (RSUs). The filing is made on Form 4 as a single-reporting-person filing for McCathron in his roles as both director and officer.
HIPO filed a Form 144 covering a planned sale of 1,819 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $57,371.26. These shares come from restricted stock units acquired from the issuer on 11/15/2025, with payment also dated 11/15/2025. The filing notes that 25,335,179 shares of common stock were outstanding, providing a baseline for the company’s total equity. Over the prior three months, a Rule 10b5-1 trading plan for Guy Zeltser reported sales of 5,177 common shares for gross proceeds of $194,031.73.
HIPO filed a Form 144 covering a planned sale of 1,819 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $57,371.26. These shares come from restricted stock units acquired from the issuer on 11/15/2025, with payment also dated 11/15/2025. The filing notes that 25,335,179 shares of common stock were outstanding, providing a baseline for the company’s total equity. Over the prior three months, a Rule 10b5-1 trading plan for Guy Zeltser reported sales of 5,177 common shares for gross proceeds of $194,031.73.